{'52WeekChange': -0.13868618,
 'SandP52WeekChange': None,
 'address1': '1540 Drew Avenue',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.19,
 'askSize': 2200,
 'averageDailyVolume10Day': 109662,
 'averageVolume': 263422,
 'averageVolume10days': 109662,
 'beta': 0.27619,
 'beta3Year': None,
 'bid': 1.1,
 'bidSize': 800,
 'bookValue': 0.171,
 'category': None,
 'circulatingSupply': None,
 'city': 'Davis',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.19,
 'dayLow': 1.12,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -9.079,
 'enterpriseToRevenue': 6.3,
 'enterpriseValue': 190926928,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.1057143,
 'fiftyTwoWeekHigh': 1.73,
 'fiftyTwoWeekLow': 0.61,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 82362998,
 'forwardEps': -0.11,
 'forwardPE': -10.272727,
 'fromCurrency': None,
 'fullTimeEmployees': 133,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.00796,
 'heldPercentInstitutions': 0.73293996,
 'industry': 'Agricultural Inputs',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/marronebio.com',
 'longBusinessSummary': 'Marrone Bio Innovations, Inc. discovers, develops, '
                        'produces, and promotes biological products for pest '
                        'management, plant nutrition, and plant health in the '
                        'United States and internationally. Its products '
                        'include Regalia, a plant extract-based fungicidal '
                        'biopesticide for plant disease and plant health; '
                        'Grandevo, a bioinsecticide for insect and mite '
                        'control; Venerate, a bioinsecticide, which controls '
                        'chewing and sucking insects and mites, as well as '
                        'flies and plant parasitic nematodes; and Majestene, a '
                        'bionematicide to control soil-dwelling nematodes by '
                        'preventing and reducing root galls, and reducing '
                        'adult reproduction and egg hatch, as well as controls '
                        'soil borne insects. The company also provides '
                        'Stargus, a biofungicide to control plant diseases, '
                        'such as Sclerotinia white molds, gray mold/bunch rot, '
                        'and downy mildews; and Haven, a plant health product '
                        'that is applied to the leaves of plants to reduce sun '
                        'stress. In addition, it offers Zequanox, a '
                        'biomolluscicide that controls invasive mussels, which '
                        'cause infrastructure and ecological damage primarily '
                        'to power and industrial companies. Additionally, the '
                        'company provides Pro Farm products for increasing '
                        'plant health, yield and quality; and Jet-Ag and '
                        'Jet-Oxide, peroxyacetic acid-based plant health '
                        'product lines that stops molds and bacteria on plants '
                        'and other surfaces. Marrone Bio Innovations, Inc. '
                        'serves agricultural and water treatment markets. The '
                        'company provides its products directly through sales '
                        'force, as well as through distributors. The company '
                        'formerly known as Marrone Organic Innovations, Inc. '
                        'Marrone Bio Innovations, Inc. was founded in 2006 and '
                        'is headquartered in Davis, California.',
 'longName': 'Marrone Bio Innovations, Inc.',
 'market': 'us_market',
 'marketCap': 168520288,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_29199209',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -40282000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.19,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '530 750 2800',
 'previousClose': 1.18,
 'priceHint': 4,
 'priceToBook': 6.6081867,
 'priceToSalesTrailing12Months': 5.560441,
 'profitMargins': -1.3291299,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.19,
 'regularMarketDayLow': 1.12,
 'regularMarketOpen': 1.19,
 'regularMarketPreviousClose': 1.18,
 'regularMarketPrice': 1.19,
 'regularMarketVolume': 101405,
 'revenueQuarterlyGrowth': None,
 'sector': 'Basic Materials',
 'sharesOutstanding': 149132992,
 'sharesPercentSharesOut': 0.0159,
 'sharesShort': 2365458,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2742962,
 'shortName': 'Marrone Bio Innovations, Inc.',
 'shortPercentOfFloat': 0.0357,
 'shortRatio': 7.82,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'MBII',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.32,
 'twoHundredDayAverage': 1.006259,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '6c139976-cb43-3c90-b465-4f3cf5c72414',
 'volume': 101405,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.marronebio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '95618'}